Andrew John Matthew Clark

CEVEC Pharmaceuticals GmbH engages in the manufacture of biopharmaceuticals using a human cell-based expression system. It provides therapeutic proteins and monoclonal antibodies. The company was founded by Stefan Kochanek in 2004 and is headquartered in Cologne, Germany.

Future Capital (Future Capital) is an independent venture capital firm which was founded in 1999 as the initiative of the Hessen State Government and Hoechst AG (now Sanofi-Aventis Group). The firm is headquartered in Frankfurt, Germany.

Creathor Venture Management GmbH is an independent private equity firm specialized in technology venture capital investing. Creathor was foundedi n 2003 and is headquartered in Bad Homburg near Frankfurt in central Germany. The management invests their own capital, and manages venture capital funds on behalf of institutions.

3i Private Equity is a private equity firm, founded in 1945. The firm is headquartered in London, United Kingdom with additional offices around the world.

Algenex SL develops and manufactures recombinant proteins. It specializes in the baculovirus vector-based innovative technologies to manufacture recombinant proteins used to produce vaccines, diagnostic reagents and therapeutic molecules. The company was founded by Jose Angel Martinez Escribano and Covadonga Alonso on January 19, 2005 and is headquartered in Pozuelo de Alarcon, Spain.

Part of Johnson & Johnson, Janssen-Cilag GmbH is a German pharmaceutical company that focuses on innovative medical research and product development to create a future where disease is no longer a concern. The company is based in Neuss, Germany. The company's Janssen Trial Finder website is designed to inform patients and healthcare professionals about participating in a Janssen clinical trial and to search for clinical trials nearby. Janssen-Cilag was founded in 1959, and Iris Zemzoum has been the CEO of the company since 2012.

Blueprint Genetics Oy engages in the provision of genetic diagnostics and clinical interpretation of hereditary diseases. It offer dignistic tests for cardiology; dermatology; endocrinology; immunology; metabolic disorder; nephrology; and pulmonology. The company was founded by Tommi Pietari Lehtonen, Juha Koskenvuo, Tero-Pekka Alastalo, and Samuel Myllykangas in 2008 and is headquartered in Helsinki, Finland.

Fort Rock Capital Ltd. provides investment services. The company is headquartered in London, the United Kingdom.

Part of Medinet Topco Ltd., Medinet Midco I Ltd. is a provider of specialised clinical teams that deliver additional elective services to the NHS. The company is based in Sutton Coldfield, UK. Medinet Midco I offers urology and dermatology insourcing services, as well as fully managed specialised clinical teams. The British company was founded in 2016 and has been helping to reduce NHS waiting times for 15 years.

Cleon Capital Advisors SL (Cleon Capital Advisors) is a private equity firm founded in 2015 by Nicola Zambon. The firm is headquartered in Madrid, Spain with additional office in Milan.

Part of Hanseatic Asset Management LBG, Hansa Capital GmbH is a Swiss company that provides investment services. The company is based in Pfäffikon, Switzerland.

Part of Greenhill & Co., Inc., Greenhill & Co. Spain Ltd. is a Spanish company that provides financial advisory services. The company is based in Madrid, Spain.

Part of Medinet Topco Ltd., Medinet Clinical Services Ltd. is a leading provider of specialised clinical teams delivering additional elective services to the NHS. The company is based in Sutton Coldfield, UK. The British company offers fully managed specialised clinical teams to help reduce NHS waiting times throughout the UK, including urology and general surgery insourcing. The company was founded in 2005 with the intention of easing the pressure on the NHS service, so that it can see and treat more patients.

Part of Medinet Topco Ltd., Medinet Midco II Ltd. functions as an investment holding British company. The company is based in Sutton Coldfield, UK and was founded in 2016.

Pregimmune Corp. is a private company based in Dover, DE. The company specializes in developing novel immunotherapies for pregnancy-related complications. The company's research focuses on understanding the immune system's role in pregnancy and developing therapies to prevent or treat complications such as preeclampsia, preterm birth, and fetal growth restriction.